What is the address of APJG MEDICAL?

The registered office of APJG MEDICAL is located at Rue de la Paix 1, 4130 Esneux.

Is APJG MEDICAL still active?

Yes. According to the CBE (31 October 2026) APJG MEDICAL is active, legal situation “Normale toestand”, started on 17 November 2021.

Is APJG MEDICAL registered on Peppol?

Yes, APJG MEDICAL is registered on the Peppol network with ID 0208:0777435697.

What is the enterprise number of APJG MEDICAL?

The enterprise number of APJG MEDICAL is BE0777435697.

When was APJG MEDICAL founded?

APJG MEDICAL was founded on 17 November 2021.

Who are the directors of APJG MEDICAL?

According to the 2025 annual accounts, the directors of APJG MEDICAL are: Anthony Giudice.

Is APJG MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 November 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APJG MEDICAL make in 2025?

APJG MEDICAL posted a profit after taxes of € 8,822 in financial year 2025.

What is the revenue of APJG MEDICAL?

As a small company, APJG MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 103,081.

APJG MEDICAL (Private Limited) - Esneux - BE0777435697

Dossier APJG MEDICAL, printed on 31 October 2026 from databakkes.be/en/0777435697/apjg-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APJG MEDICAL from Esneux, company number BE0777435697, closed financial year 2025 with a result of € 8,822 after tax. For that financial year APJG MEDICAL recorded a gross margin of € 103,081 and equity of € 57,048. Compared with financial year 2024, the result moved from € 86,824 to € 8,822. The company is profitable. The buffer shrank hard: equity is 77 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.

What it is worth Shrank hard

€ 57,048

▼ 77% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,822

▼ 90% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 193,247

▼ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 200,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 50,211

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,892

▼ 25% vs 2024

€ 11,898 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Taxes

€ 30,000

▲ 50% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 76,523 Gross margin 2022: € 76,523 First fiscal year in the series	€ 127,906 Gross margin 2023: € 127,906 ▲ 67% vs 2022 (€ 76,523) Favourable step	€ 117,292 Gross margin 2024: € 117,292 ▼ 8% vs 2023 (€ 127,906) Unfavourable step	€ 103,081 Gross margin 2025: € 103,081 ▼ 12% vs 2024 (€ 117,292) Unfavourable step	▼ 12%
Profit after taxes	€ 60,937 Profit after taxes 2022: € 60,937 First fiscal year in the series	€ 98,464 Profit after taxes 2023: € 98,464 ▲ 62% vs 2022 (€ 60,937) Favourable step	€ 86,824 Profit after taxes 2024: € 86,824 ▼ 12% vs 2023 (€ 98,464) Unfavourable step	€ 8,822 Profit after taxes 2025: € 8,822 ▼ 90% vs 2024 (€ 86,824) Unfavourable step	▼ 90%
Equity	€ 62,937 Equity 2022: € 62,937 First fiscal year in the series	€ 161,402 Equity 2023: € 161,402 ▲ 156% vs 2022 (€ 62,937) Favourable step	€ 248,226 Equity 2024: € 248,226 ▲ 54% vs 2023 (€ 161,402) Favourable step	€ 57,048 Equity 2025: € 57,048 ▼ 77% vs 2024 (€ 248,226) Unfavourable step	▼ 77%
Total debts	€ 16,664 Total debts 2022: € 16,664 First fiscal year in the series	€ 81,096 Total debts 2023: € 81,096 ▲ € 64,432 vs 2022 (€ 16,664) Unfavourable step	€ 66,537 Total debts 2024: € 66,537 ▼ 18% vs 2023 (€ 81,096) Favourable step	€ 209,871 Total debts 2025: € 209,871 ▲ 215% vs 2024 (€ 66,537) Unfavourable step	▲ 215%
Cash	€ 76,282 Cash 2022: € 76,282 First fiscal year in the series	€ 175,802 Cash 2023: € 175,802 ▲ 130% vs 2022 (€ 76,282) Favourable step	€ 227,239 Cash 2024: € 227,239 ▲ 29% vs 2023 (€ 175,802) Favourable step	€ 193,247 Cash 2025: € 193,247 ▼ 15% vs 2024 (€ 227,239) Unfavourable step	▼ 15%
Retained profit	€ 60,937 Retained profit 2022: € 60,937 First fiscal year in the series	€ 159,402 Retained profit 2023: € 159,402 ▲ 162% vs 2022 (€ 60,937) Favourable step	€ 246,226 Retained profit 2024: € 246,226 ▲ 54% vs 2023 (€ 159,402) Favourable step	€ 55,048 Retained profit 2025: € 55,048 ▼ 78% vs 2024 (€ 246,226) Unfavourable step	▼ 78%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 200,000 Dividend 2025: € 200,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 56,312 Bank debt 2023: € 56,312 Unchanged (€ 0) Unfavourable step	€ 45,327 Bank debt 2024: € 45,327 ▼ 20% vs 2023 (€ 56,312) Favourable step	€ 33,892 Bank debt 2025: € 33,892 ▼ 25% vs 2024 (€ 45,327) Favourable step	▼ 25%
Balance sheet total	€ 79,601 Balance sheet total 2022: € 79,601 First fiscal year in the series	€ 242,498 Balance sheet total 2023: € 242,498 ▲ 205% vs 2022 (€ 79,601) Unchanged	€ 314,762 Balance sheet total 2024: € 314,762 ▲ 30% vs 2023 (€ 242,498) Unchanged	€ 266,918 Balance sheet total 2025: € 266,918 ▼ 15% vs 2024 (€ 314,762) Unchanged	▼ 15%

Key figures of APJG MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 October 2026.

What happened to APJG MEDICAL?

What happened at APJG MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 29, 2025 New annual accounts for financial year 2025: profit of € 8,822 (▼ 90% vs 2024). Source: NBB ↗
Nov 17, 2021 New establishment in Esneux. KBO
Nov 17, 2021 Start of the company according to the CBE. KBO

In short

From € 60,937 profit in 2022 to € 8,822 profit in 2025.

Paid € 73,193 in corporate taxes since 2022.

Best year ever: 2023, with € 98,464 profit.

Paid out € 200,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Anthony Giudice

APJG MEDICAL

Behind APJG MEDICAL is Anthony Giudice.

Directors

According to the 2025 annual accounts

Anthony Giudice

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Paix 1

4130 Esneux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0777.435.697
VAT number: BE 0777.435.697
Registered office: Rue de la Paix 1, 4130 Esneux
Names & denominations: APJG MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 November 2021
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗